CD38-directed Antibody Interactions

Name
CD38-directed Antibody Interactions
Accession Number
DBCAT004459
Description

Not Available

Drugs
DrugDrug Description
DaratumumabA CD38-directed cytolytic antibody used alone or as an adjunct drug in the treatment of multiple myeloma.
IsatuximabA chimeric monoclonal antibody targeted against surface CD38 glycoproteins for the treatment of multiple myeloma in patients who have failed previous therapies.
Drugs & Drug Targets
DrugTargetType
DaratumumabADP-ribosyl cyclase 1target
IsatuximabADP-ribosyl cyclase 1target